12.14.24 -- Life Science Leader Best Of November

Anne Zimmerman, editor-in-chief of the Columbia University online journal, Voices in Bioethics, discusses her concerns over the use of GLP-1 weight loss drugs in the U.S.

Job rotations provide an opportunity for promising, high-potential employees to grow and learn new parts of the business. Kristina Fusella describes the challenges and multifactorial benefits of job rotations as a tool for leadership development at Novo Nordisk.

Explore part two of a two-part series that identifies current uses of AI in drug discovery and development and assesses whether AI tools improve the probability of success and likelihood of drug approval.

Gain insight into the promising life sciences investment a global healthcare and medtech company is planning to make for a new biologics manufacturing facility focusing on the production of mAbs.

Explore key drugs anticipated for 2025, spanning oncology, neurology, autoimmune disorders, and infectious diseases, with potential for significant market impact and new treatment paradigms.

Life sciences companies are grappling with a deluge of data. Yet strategic data management outsourcing offers potential benefits amidst regulatory and interoperability hurdles.